(VIANEWS) – Blackrock Limited Duration Income Trust (BLW), AbbVie (ABBV), Patterson Companies (PDCO) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Blackrock Limited Duration Income Trust (BLW) 17.29 0.41% 6.93% 2021-07-08 20:39:23
2 AbbVie (ABBV) 117.91 0.24% 4.53% 2021-07-13 15:35:45
3 Patterson Companies (PDCO) 30.47 1.84% 3.42% 2021-07-11 12:11:11
4 Western Asset/Claymore Inflation (WIW) 13.20 0% 3.38% 2021-07-10 07:14:26
5 Auburn National Bancorporation (AUBN) 34.66 -0.89% 2.94% 2021-07-10 11:46:08
6 NextEra Energy (NEE) 74.86 -0.31% 2.08% 2021-07-13 16:14:23

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Blackrock Limited Duration Income Trust (BLW) – Dividend Yield: 6.93%

BlackRock Limited Duration Income Trust is a close ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income securities of the United States. It invests in securities of companies operating across diversified sectors. The fund primarily invests in investment grade corporate bonds, mortgage-related securities, asset-backed securities, US Government and agency securities, and senior, secured floating rate loans. It has an average portfolio duration of less than five years. The fund benchmarks the performance of its portfolio against the Lehman Brothers U.S. Aggregate Index. BlackRock Limited Duration Income Trust was formed on July 31, 2003 and is domiciled in the United States.

Volume

Today’s last reported volume for Blackrock Limited Duration Income Trust is 50634, 38.36% below its average volume of 82144.

Blackrock Limited Duration Income Trust’s last close was $17.04, 1.5% under its 52-week high of $17.30.

Blackrock Limited Duration Income Trust’s Stock Yearly Top and Bottom Value

Blackrock Limited Duration Income Trust’s stock is valued at $17.29 at 00:15 EST, under its 52-week high of $17.30 and way higher than its 52-week low of $13.96.

Blackrock Limited Duration Income Trust’s Moving Average

Blackrock Limited Duration Income Trust’s worth is higher than its 50-day moving average of $17.06 and higher than its 200-day moving average of $16.47.

More news about Blackrock Limited Duration Income Trust.

2. AbbVie (ABBV) – Dividend Yield: 4.53%

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Volume

Today’s last reported volume for AbbVie is 5304920, 17.16% below its average volume of 6403620.

AbbVie’s last close was $117.63, 0.61% under its 52-week high of $118.35.

AbbVie’s Sales

AbbVie’s sales growth is 34.9% for the current quarter and 10.5% for the next. The company’s growth estimates for the present quarter and the next is 31.6% and 14.5%, respectively.

AbbVie’s Revenue

Year-on-year quarterly revenue growth grew by 50.9%, now sitting on 50.2B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AbbVie’s stock is considered to be oversold (<=20).

AbbVie’s Stock Yearly Top and Bottom Value

AbbVie’s stock is valued at $117.91 at 00:15 EST, below its 52-week high of $118.35 and way above its 52-week low of $79.11.

AbbVie’s Moving Average

AbbVie’s value is above its 50-day moving average of $114.30 and above its 200-day moving average of $110.02.

More news about AbbVie.

3. Patterson Companies (PDCO) – Dividend Yield: 3.42%

Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; technology solutions, such as practice management software and e-commerce solutions; patient education systems; and office forms and stationery. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.

Volume

Today’s last reported volume for Patterson Companies is 583959, 40.61% below its average volume of 983325.

Patterson Companies’s last close was $32.54, 12.92% under its 52-week high of $37.37.

The company’s growth estimates for the ongoing quarter is 12.1% and a drop 19% for the next.

Patterson Companies’s Revenue

Year-on-year quarterly revenue growth grew by 21.4%, now sitting on 5.91B for the twelve trailing months.

Patterson Companies’s Stock Yearly Top and Bottom Value

Patterson Companies’s stock is valued at $30.47 at 00:15 EST, way below its 52-week high of $37.37 and way above its 52-week low of $22.15.

Patterson Companies’s Moving Average

Patterson Companies’s worth is under its 50-day moving average of $33.09 and under its 200-day moving average of $32.64.

More news about Patterson Companies.

4. Western Asset/Claymore Inflation (WIW) – Dividend Yield: 3.38%

Western Asset/Claymore Inflation-Linked Opportunities & Income Fund is a closed-ended fixed income mutual fund launched and managed by Guggenheim Funds Investment Advisors, LLC. It is managed by Western Asset Management Company, Western Asset Management Company Limited, Western Asset Management Company Ltd., and Western Asset Management Company Pte. Ltd. The fund invests in fixed income markets across the globe. It primarily invests in investment grade inflation-linked securities with an average effective duration of between zero and 15 years. The fund benchmarks the performance of its portfolio against the Barclays U.S. Government Inflation-Linked 1-10 Year Index and the Barclays U.S. Government Inflation-Linked All Maturities Index. Western Asset/Claymore Inflation-Linked Opportunities & Income Fund was formed on February 24, 2004 and is domiciled in the United States.

Volume

Today’s last reported volume for Western Asset/Claymore Inflation is 68630, 34.73% below its average volume of 105148.

Western Asset/Claymore Inflation’s last close was $12.94, 2.49% under its 52-week high of $13.27.

Western Asset/Claymore Inflation’s Revenue

Year-on-year quarterly revenue growth declined by 23.5%, now sitting on 29.62M for the twelve trailing months.

Western Asset/Claymore Inflation’s Stock Yearly Top and Bottom Value

Western Asset/Claymore Inflation’s stock is valued at $13.20 at 00:15 EST, below its 52-week high of $13.27 and way above its 52-week low of $11.04.

Western Asset/Claymore Inflation’s Moving Average

Western Asset/Claymore Inflation’s worth is higher than its 50-day moving average of $13.02 and higher than its 200-day moving average of $12.52.

More news about Western Asset/Claymore Inflation.

5. Auburn National Bancorporation (AUBN) – Dividend Yield: 2.94%

Auburn National Bancorporation, Inc. operates as the bank holding company for AuburnBank that provides various banking products and services in East Alabama. The company's deposit products include checking, savings, and transaction deposit accounts, as well as certificates of deposit. It also provides commercial, financial, agricultural, real estate construction, and consumer loan products; residential mortgage lending services; and other financial services. In addition, the company offers automated teller services; debit cards; online banking, bill payment, and other electronic services; and safe deposit boxes. It operates through its main office; eight full-service branches in Auburn, Opelika, Notasulga, and Valley, Alabama; and a commercial loan production office in Phenix City, Alabama. Auburn National Bancorporation, Inc. was founded in 1907 and is headquartered in Auburn, Alabama.

Volume

Today’s last reported volume for Auburn National Bancorporation is 6996, 39.72% below its average volume of 11606.

Auburn National Bancorporation’s last close was $38.20, 24.39% below its 52-week high of $50.52.

Auburn National Bancorporation’s Revenue

Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 28.68M for the twelve trailing months.

Auburn National Bancorporation’s Stock Yearly Top and Bottom Value

Auburn National Bancorporation’s stock is valued at $34.66 at 00:15 EST, way below its 52-week high of $50.52 and above its 52-week low of $33.91.

Auburn National Bancorporation’s Moving Average

Auburn National Bancorporation’s worth is under its 50-day moving average of $36.45 and way under its 200-day moving average of $38.78.

More news about Auburn National Bancorporation.

6. NextEra Energy (NEE) – Dividend Yield: 2.08%

NextEra Energy, Inc., through its subsidiaries, generates, transmits, and distributes electric power in North America. The company generates electricity through wind, solar, nuclear, coal, oil, and natural gas facilities. It also develops, constructs, and operates long-term contracted assets with a focus on renewable generation facilities, natural gas pipelines, and battery storage projects; and owns, develops, constructs, manages, and operates electric generation facilities in wholesale energy markets. In addition, the company engages in the energy-related commodity marketing and trading activities. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in May 2010. NextEra Energy, Inc. was founded in 1925 and is headquartered in Juno Beach, Florida.

Volume

Today’s last reported volume for NextEra Energy is 4957460, 34.13% below its average volume of 7526440.

NextEra Energy’s last close was $75.09, 14.37% below its 52-week high of $87.69.

NextEra Energy’s Sales

NextEra Energy’s sales growth is a negative 3.8% for the present quarter and 15.4% for the next. The company’s growth estimates for the present quarter and the next is 4.6% and 10.6%, respectively.

NextEra Energy’s Revenue

Year-on-year quarterly revenue growth declined by 19.2%, now sitting on 17.11B for the twelve trailing months.

NextEra Energy’s Stock Yearly Top and Bottom Value

NextEra Energy’s stock is valued at $74.86 at 00:15 EST, way under its 52-week high of $87.69 and way higher than its 52-week low of $62.94.

NextEra Energy’s Moving Average

NextEra Energy’s worth is above its 50-day moving average of $73.55 and under its 200-day moving average of $76.40.

More news about NextEra Energy.

LEAVE A REPLY

Please enter your comment!
Please enter your name here